During the past decade, Soltero Cardiovascular Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Soltero Cardiovascular Research Center" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Merit Medical Systems, Inc." with 1 trials sponsored and "Metavention" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Soltero Cardiovascular Research Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Soltero Cardiovascular Research Center" are "Heart Failure" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Atrial Flutter" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Soltero Cardiovascular Research Center" in a lesser frequency.

Most popular intervention types in "Soltero Cardiovascular Research Center" are "Drug" (5 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (2 trials), "Evolocumab" (1 trials), "Inclisiran sodium 300 mg" (1 trials) and "Merit WRAPSODY Endovascular Stent Graft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Soltero Cardiovascular Research Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Soltero Cardiovascular Research Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Soltero Cardiovascular Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Soltero Cardiovascular Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".